Search

everythinglearnresearchcommunity

for

Search:↓

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

The document provides 70 multiple choice questions to improve haematology skills.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Certain bacteria and fungi are linked to healthy scalps and dandruff, suggesting that the scalp's microbial balance affects its health.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Abatacept may help some people with alopecia areata regrow hair.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Autoimmune reactions may cause both alopecia areata and HAM.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Combining stem cells with ATP significantly boosts hair regrowth in mice with hair loss.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

The combination therapy was effective and well-tolerated, especially in young patients.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.